MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, OCGN had $5,554K increase in cash & cash equivalents over the period. -$13,007K in free cash flow.

Cash Flow Overview

Change in Cash
$5,554K
Free Cash flow
-$13,007K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-20,051 -30,089
Depreciation and amortization expense
950 1,836
Non-cash interest expense
25 50
Non-cash lease expense
324 620
Non-cash (income) expense from collaborative arrangements, net
918 1,766
Stock-based compensation expense
1,975 3,730
Other
-9 -20
Prepaid expenses and other current assets
-795 2,708
Lease obligations
--596
Accounts payable and accrued expenses
3,289 -1,184
Other non-current liabilities
90 -
Net cash used in operating activities
-12,916 -30,087
Purchases of property and equipment
91 59
Payment of security deposits
-5 131
Net cash used in investing activities
-86 -190
Issuance of common stock and warrants, net
18,326 -
Payment of eb-5 loan
0 1,000
Payments from issuance of common stock, net
-184
Net cash provided by financing activities
18,510 -1,184
Effect of changes in exchange rate on cash and restricted cash
46 -36
Net decrease in cash and restricted cash
5,554 -31,497
Cash and cash equivalents at beginning of period
58,821 -
Cash and cash equivalents at end of period
32,879 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Ocugen, Inc. (OCGN)

Ocugen, Inc. (OCGN)